Kentucky Society of Clinical Oncology

The Kentucky Society of Clinical Oncology focuses on providing our members with the most up to date information regarding patient care and practice management.

[Kentucky Society of Clinical Oncology @kyscocancer]

"... Through its screening program, St. Elizabeth has diagnosed its 500th case, marking a momentous achievement in the fight against this previously silent killer." Read more...
https://t.co/2GFrPBOjVL

[Kentucky Society of Clinical Oncology @kyscocancer]

"Biomarker testing is a key tool in lung cancer treatment, and smoking-related lung cancer remains common in states such as Kentucky and Tennessee..." https://t.co/lmJ6ws90uV

[Kentucky Society of Clinical Oncology @kyscocancer]

Communities of color and rural America are disproportionately impacted by cancer. The re-introduced Nancy Gardner Sewell Medicare MCED Screening Coverage Act creates a pathway for Medicare to cover #MCED tests, and close existing health inequity gaps. https://t.co/ofDH00vbvY.

[Kentucky Society of Clinical Oncology @kyscocancer]

NCCN State Oncology Society Forum is discussing how value based models can reduce cost and improve outcomes. @goetzkloecker

[Kentucky Society of Clinical Oncology @kyscocancer]

Expanding access to biomarker testing will ensure KY patients can get the right treatment at the right time. Thank you Rep. @5boymom for your work on #HB180 and to the members of the House Health Services Committee for moving the legislation to the full #KYHouse! #kyga23

[Kentucky Society of Clinical Oncology @kyscocancer]

Significantly, Kentucky is a leader in lung cancer statewide initiatives such as the KY LEADS Collaborative, the KY Health Collaborative, the Kentucky Cancer Consortium, and the KY Cancer Program. Read more! https://t.co/gYQFrWcFy0

[Kentucky Society of Clinical Oncology @kyscocancer]

We had a great meeting with @ACSCANKY and @RepGuthrie today about the #Medicare Multi-Cancer #earlydetection Screening Coverage Act. This legislation is key to end late-stage cancer & save lives. Thank you, Rep. Guthrie, for making #MCED a top priority!

[Kentucky Society of Clinical Oncology @kyscocancer]

Happening now! Dr. Neal Dunlap is discussing improvements in radiation therapy in the treatment of lung cancer.

[Kentucky Society of Clinical Oncology @kyscocancer]

Happening now! Dr. Royce Calhoun is discussing improvements in surgical approaches in lung cancer treatment.

[Kentucky Society of Clinical Oncology @kyscocancer]

Join us! Tomorrow morning, Katie Barrett, BSN & Jennifer Mulholland, BSN, with St. Elizabeth Healthcare, will discuss the role of oncology nurse navigators and clinical pathways to decrease the time to treatment for lung cancer patients. Register Now! https://t.co/fLu5yoKvo9

[Kentucky Society of Clinical Oncology @kyscocancer]

Join us! Tomorrow morning, Bradley Gibson, M.D., Pathologist and Immunohistochemistry Director at Pathology and Cytology Labs, Lexington, KY, will discuss the post-diagnostic therapeutic testing for NSCLC. Register Now! https://t.co/sRkdbr0TJU

[Kentucky Society of Clinical Oncology @kyscocancer]

Join us! Tomorrow morning, Neal Dunlap, MD, will discuss the role of stereotactic body radiation therapy (SBRT) in the management of early stage NSCLC and how SBRT can be integrated into immunotherapy management strategies. Register Now! https://t.co/rYb06SYgKw

[Kentucky Society of Clinical Oncology @kyscocancer]

Join us! Tomorrow morning, Jason Chesney, M.D., Ph.D., will discuss the mechanism of action of TILs in NSCLC patients and brief attendees on the criteria for enrollment of NSCLC patients in TIL clinical trials. Register Now! https://t.co/8tWLSvudEe

[Kentucky Society of Clinical Oncology @kyscocancer]

#earlydetection is key to beating cancer. The Multi-Cancer Early Detection Screening Act has broad bipartisan support & will help seniors access the latest cancer screening tools. @LeaderMcConnell

[Kentucky Society of Clinical Oncology @kyscocancer]

Join tomorrow! 2022 ACS CAN Kentucky Coffee Club: Lung Cancer: Screenings, Biomarkers, and New Technologies at 9 a.m. EST, 11/16.

When you are ready to join the meeting, please join us via https://t.co/COwsg8JrE5

[Oncology Brothers @OncBrothers]

#Mirvetuximab soravtansine-gynx now @FDAOncology approved for FRα +ve, plat-resistant epithelial ovarian, Fallopian tube, or 1° peritoneal Ca post 1-3L of Rx.

- Assay-Ventana FOLR1 (FOLR-2.1)
- #SORAYA: Ph3, n=106, ORR 31.7%, CR:4.8%, mDOR of 6.9 mos

#MedTwitter #OncEd #Gynsm

[Kentucky Society of Clinical Oncology @kyscocancer]

Listen Now! "2022 GI ESMO Update" at https://t.co/q2gVWlt2Au

[Markey Cancer Center @UKMarkey]

REMINDER: Join us on Oct. 28 to hear Dr. Radhakrishnan, PhD, discuss “Modeling the Physical Biology of Cancer Engineering at Molecular and Tissue Scales.”

9:00 AM EDT | 6:30 PM IST | UTC- 4:00

To register: https://t.co/8B9F1FiQiY

For more information: [email protected]

[Kentucky Society of Clinical Oncology @kyscocancer]

ATTN: @NCCN updated the designation of our cancer treatment to Preferred Regimen in its Clinical Practice Guidelines in Oncology. Read more here: https://t.co/lLKZN6yuQO

[Aman Chauhan @AmanChauhanMD]

@docameya @NANETS1 @UKMarkey Likewise. Coffee is on me and lets leave the meeting with a collaborative Indo-US project.